A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Name: A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma
Published: 2022
License: Public Domain

Lakefront Biotherapeutics NV · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

amp

relapsed/refractory b-cell non-hodgkin lymphoma, lymphomas non-hodgkin&amp;#39;s b-cell, non-hodgkin lymphoma (nhl), follicular lymphoma (fl), marginal zone lymphoma (mzl), mantle cell lymphoma (mcl), burkitt lymphoma (bl), primary central nervous system lymphoma (pcnsl), diffuse large b-cell lymphoma (dlbcl), car t-cell therapy, diffuse large b-cell lymphoma - richter transformation (dlbcl-rt), small lymphocytic leukemia (sll)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 845179
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.